Atlas Trials

Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery

Clinical trial NCT02137161 · COMPLETED

Trial details

NCT number
NCT02137161
Sponsor
Azienda USL Reggio Emilia - IRCCS
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
CataractPseudoexfoliation Syndrome
Start date
2013-11-01
Primary completion
2014-10-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.